Adrenal atrophy CT

Adrenal atrophy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adrenal atrophy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adrenal atrophy CT On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adrenal atrophy CT All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adrenal atrophy CT
CDC on Adrenal atrophy CT
Adrenal atrophy CT in the news
Blogs on Adrenal atrophy CT
Directions to Hospitals Treating Adrenal atrophy
Risk calculators and risk factors for Adrenal atrophy CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

A CT of the adrenal glands can be used to check for structural abnormalities of the adrenal glands.

CT

The bilateral atrophy of the adrenal gland is shown in the following figure:ref name="pmid32264857">Inaba H, Ariyasu H, Iwakura H, Kurimoto C, Ueda Y, Uraki S, Takeshima K, Furukawa Y, Morita S, Nakayama Y, Ohashi T, Ito H, Nishimura Y, Akamizu T (April 2020). "Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis: case report". BMC Endocr Disord. 20 (1): 47. doi:10.1186/s12902-020-0498-5. PMC 7140544 . PMID 32264857 .</ref>